A randomised, controlled, factorial pilot study investigating Omacor [omega-3 ethylester concentrate] and/or Fluvastatin in patients with chronic hepatitis C who have not responded to standard combination anti viral therapy.

Trial Profile

A randomised, controlled, factorial pilot study investigating Omacor [omega-3 ethylester concentrate] and/or Fluvastatin in patients with chronic hepatitis C who have not responded to standard combination anti viral therapy.

Completed
Phase of Trial: Phase II

Latest Information Update: 31 Jul 2017

At a glance

  • Drugs Fluvastatin (Primary) ; Omega-3-acid ethyl esters (Primary)
  • Indications Hepatitis C
  • Focus Pharmacodynamics
  • Acronyms HCV Lipid
  • Most Recent Events

    • 26 Apr 2013 Results presented at the 48th Annual Meeting of the European Association for the Study of the Liver.
    • 12 Jul 2011 New source identified and integrated (European Clinical Trials Database; EudraCT2006-004335-29).
    • 20 May 2010 United Kingdom Clinical Research Network has reported actual end date as 5 Nov 2009.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top